ArticlePloS one2026
Spatiotemporal analysis of psychoactive drug consumption in Brazil during the COVID-19 pandemic.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic had a significant impact on Brazil, although its effects were not homogeneous across the country. Socioeconomic disparities may influence epidemiological patterns during health emergencies, which impact population mental health. This study aimed to analyze the consumption of psychoactive medicines during the COVID-19 pandemic in Brazil and to characterize its spatiotemporal dynamics, identifying associated social, economic, and demographic factors. We used publicly available retail pharmacies dispensing data from January 2018 to September 2021 across Brazil's municipalities. A statistical model was developed based on indicators of infrastructure, human capital, and labor and income. Generalized additive models were used to characterize the spatiotemporal distribution of drug consumption. In September 2021, average consumption in municipalities reporting COVID-19-related deaths was 22% higher than in municipalities with no reported deaths. Among the most frequently consumed medicines during the study period, second-generation antidepressants were predominant. Life expectancy, employment and education showed positive linear associations with consumption, whereas inadequate water supply and sanitation were inversely associated. Municipality income was positively associated with average consumption of psychoactive medicines, but those with a very high-income development index showed more complex dynamics. Our results suggest that COVID-19 mortality was associated with psychotropic medicines consumption and indicate the need to address socioeconomic vulnerability as a key component of public health emergency response. The COVID-19 pandemic had a significant impact on Brazil, although its effects were not homogeneous across the country. Socioeconomic disparities may influence epidemiological patterns during health emergencies, impacting population mental health. This study aimed to analyze the consumption of psychoactive medicines during the COVID-19 pandemic in Brazil and to characterize its spatiotemporal dynamics, identifying associated social, economic, and demographic factors. We used publicly available data from retail pharmacy dispensing from January 2018 to September 2021 across Brazilian municipalities. A statistical model was developed based on indicators of infrastructure, human capital, labor, and income. Generalized additive models were used to characterize the spatiotemporal distribution of drug consumption. In September 2021, average consumption in municipalities reporting COVID-19-related deaths was 22% higher than in municipalities with no reported deaths. Among the most frequently consumed medicines during the study period, second-generation antidepressants were predominant. Life expectancy, employment, and education showed positive linear associations with consumption, whereas inadequate water supply and sanitation were inversely associated. Municipality income was positively associated with the average consumption of psychoactive medicines, but those with a very high human development index for income showed more complex dynamics. Our results suggest that COVID-19 mortality was associated with psychotropic medicine consumption and indicate the need to address socioeconomic vulnerability as a key component of public health emergency responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.